share_log
Moomoo 24/7 ·  Mar 27 07:39
Pyxis Oncology Completed The Sale Of Its Rights To Royalties From The Commercialization Of Beovu (Brolucizumab-dbll) And Another Asset To Novartis For $8M
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment